AffloVest is a proven high frequency chest wall oscillation (HFCWO) therapy designed to provide patients the freedom and mobility to customize and enhance airway clearance therapy, help mobilize lung secretions, and promote treatment adherence for patients struggling with chronic respiratory conditions. AffloVest is the first fully mobile during use HFCWO vest, and does not utilize bulky generators or air bladder technology.
The AffloVest requires a prescription for treatment by HFCWO. Once your healthcare team has decided AffloVest is the airway clearance therapy for you, they can fill out the AffloVest Order form, provide all necessary insurance and medical documentation, and contact a Durable Medical Equipment (DME) distributor to place the AffloVest order.
The AffloVest has received the FDA’s 510k clearance for U.S. market availability, and is approved for Medicare, Medicaid, and private health insurance reimbursement under the Healthcare Common Procedure Coding System (HCPCS) code E0483 – High Frequency Chest Wall Oscillation. The AffloVest is available through the U.S. Department of Veterans Affairs/Tricare. Patients must qualify for coverage and meet their individual insurance’s eligibility requirements.
Coverage criteria and documentation requirements can vary from patient to patient, largely depending on their medical condition, and their health insurance carrier and plan. Work with your healthcare team to decide if AffloVest airway clearance therapy is right for you.
With treatments often being prescribed for daily sessions, it’s important to have a therapy that fits into a patient’s daily life – not the other way around.
AffloVest is shown to be effective at1:
- Reducing antibiotic prescriptions
- Decreasing hospitalizations
- Reducing outpatient visits
